Factors affecting medication discontinuation in patients with overactive bladder symptoms
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김영미[김영미] | - |
dc.contributor.author | 김동욱[김동욱] | - |
dc.contributor.author | 심은정[심은정] | - |
dc.contributor.author | 유은희[유은희] | - |
dc.date.accessioned | 2021-08-02T15:48:38Z | - |
dc.date.available | 2021-08-02T15:48:38Z | - |
dc.date.created | 2016-10-20 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2287-8572 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/45728 | - |
dc.description.abstract | Objective To find out the factors affecting medication discontinuation in patients with overactive bladder (OAB) symptoms. Methods The clinical data of 125 patients with OAB symptoms who had taken antimuscarinics and behavioral therapy were retrospectivelyreviewed. Antimuscarinics related outcomes were evaluated by an independent observer with telephone interview. All patients were asked about duration of medication and reason of continuation or discontinuation of antimuscarinics. To determine pre-treatment factors predicting self-report discontinuation of antimuscarinics, variables of only those with P-values <0.25 on the univariate analysis were included in the Cox proportional hazard modeling. Results Mean follow-up was 39.6 months and the proportion of discontinuation of antimuscarinics was 60.0% (75/125). The mean duration of medication was 21.2 months in the continuation group and 3.3 months in the discontinuationgroup. The reasons of discontinuation of antimuscarinics were improved OAB symptoms (46.7%), tolerable OAB symptoms (33.3%), no change of OAB symptoms (1.3%), side-effects (8.0%) and no desire to take long-term medication(10.7%). The variables affecting remaining cumulative probability of antimuscarinics were age, history of anti-incontinence surgery or vaginal surgery, and having stress predominant urinary incontinence on urodynamic study. Conclusion The lower rate of cumulative continuation of antimuscarinics encourages us to give a more detailed counseling and education to the patients with OAB symptoms before prescription. And explorations about newer agent and non-pharmacologic treatment with good efficacy and lower side-effects are needed. | - |
dc.publisher | 대한산부인과학회 | - |
dc.subject | Discontinuation | - |
dc.subject | Muscarinic antagonists | - |
dc.subject | Urinary bladder | - |
dc.subject | overactive | - |
dc.title | Factors affecting medication discontinuation in patients with overactive bladder symptoms | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 김동욱[김동욱] | - |
dc.identifier.doi | 10.5468/ogs.2015.58.6.507 | - |
dc.identifier.bibliographicCitation | Obstetrics & Gynecology Science, v.58, no.6, pp.507 - 513 | - |
dc.relation.isPartOf | Obstetrics & Gynecology Science | - |
dc.citation.title | Obstetrics & Gynecology Science | - |
dc.citation.volume | 58 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 507 | - |
dc.citation.endPage | 513 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002048152 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Discontinuation | - |
dc.subject.keywordAuthor | Muscarinic antagonists | - |
dc.subject.keywordAuthor | Urinary bladder | - |
dc.subject.keywordAuthor | overactive | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu
COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.